Private CRO expands into Armenia

US and China-based CRO FMD K&L has expanded into Armenia with a new office to support clients’ needs in the region and grow the company’s business further in Europe.  

This office will support services including study management, data management, biostatistics, programming, clinical data interchange standards consortium (CDISC)-compliant eSubmission, medical writing, such as protocol development and report writing, monitoring of European clinical sites, and safety handling.

Client Development Director Kirit Velani told Outsourcing-Pharma.com that the opening of the office was all about its location as it’s “extremely desirable for any company looking to introduce themselves into the European market because Armenia can be viewed as the gateway to Europe. Now that FMD K&L Inc. has located a branch within Armenia, they have ideally situated themselves in between the US and China, two large regions within the pharmaceutical industry.”

FMD is also already looking to expand its staff in Europe.

"We are looking to expand to a larger space in the coming months, growing our staff from 18 to 30 in 2015 and to 60 by the end of 2016," Velani added.